KR102279861B1 - Method for extract of citrus preicarp and composition for preventing, improving or treating liver injury - Google Patents

Method for extract of citrus preicarp and composition for preventing, improving or treating liver injury Download PDF

Info

Publication number
KR102279861B1
KR102279861B1 KR1020190048840A KR20190048840A KR102279861B1 KR 102279861 B1 KR102279861 B1 KR 102279861B1 KR 1020190048840 A KR1020190048840 A KR 1020190048840A KR 20190048840 A KR20190048840 A KR 20190048840A KR 102279861 B1 KR102279861 B1 KR 102279861B1
Authority
KR
South Korea
Prior art keywords
nobiletin
dimethyl
mixture
solvent
extract
Prior art date
Application number
KR1020190048840A
Other languages
Korean (ko)
Other versions
KR20200125086A (en
Inventor
박재규
박충서
우제태
Original Assignee
박재규
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박재규 filed Critical 박재규
Priority to KR1020190048840A priority Critical patent/KR102279861B1/en
Publication of KR20200125086A publication Critical patent/KR20200125086A/en
Application granted granted Critical
Publication of KR102279861B1 publication Critical patent/KR102279861B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Abstract

본 발명은 청귤류로부터 아래와 같은 추출방법을 통하여 5-O-디메틸노빌레틴을 추출 분리하는 방법의 발명으로,
① 청귤류 열매 혹은 착즙부산물을 분쇄기를 통해 분쇄하는 단계;
② 상기 분쇄물을 극성 용매인 에틸아세테이트 또는 이염화메틸렌를 이용하여 추출하는 단계;
③ 활성탄소(activated carbon)을 이용하여 추출물에 함유되어 있는 불순물 또는 색소물질을 제거단계;
④ 알칼리수인 NaOH를 이용하여 추출물에 잔류하는 농약성분 등을 제거한 후 물로 세척하여 알칼리 제거하고 진공건조시켜 분말을 수득하는 진공건조단계;
⑤ 용매인 노말-헥산 : 에틸아세테이트를 2 : 1의 비율로 한 후 컬럼 부피의 20배를 short silicagel column으로 통과시켜 노빌레틴과 시네세틴을 제거하고, 탄제레틴과 5-O-디메틸 노빌레틴의 혼합물을 분리하는 단계;
⑥ 탄제레틴과 5-O-디메틸 노빌레틴의 혼합물을 농축단계;
⑦ 혼합물을 이염화메틸렌에 녹여 -20℃에서 6시간동안 방치하여 용매 및 혼합물(tangeretin은 용매에 녹아 있는 상태임)과 5-O-디메틸 노빌레틴 결정을 분리하는 단계;
⑧ 진공에서 잔류용매 혼합물을 제거 후, 최종 결정물인 5-O-디메틸노빌레틴을 수득하는 단계;로 구성되어 있다.
The present invention is an invention of a method for extracting and separating 5-O-dimethyl nobiletin from green citrus fruits through the following extraction method,
① pulverizing green citrus fruits or juice by-products through a grinder;
② extracting the pulverized product using ethyl acetate or methylene dichloride as a polar solvent;
③ removing impurities or coloring matter contained in the extract using activated carbon;
④ A vacuum drying step of removing the pesticide components remaining in the extract using NaOH, which is alkaline water, washing with water to remove alkali, and vacuum drying to obtain a powder;
⑤ After using the solvent, normal-hexane:ethyl acetate in a ratio of 2:1, 20 times the volume of the column was passed through a short silicagel column to remove nobiletin and synacetin, and to remove tangerine and 5-O-dimethyl nobiletin. separating the mixture;
⑥ Concentrating the mixture of tangeretin and 5-O-dimethyl nobiletin;
⑦ Dissolving the mixture in methylene dichloride and leaving it at -20°C for 6 hours to separate the solvent and the mixture (tangeretin is dissolved in the solvent) and 5-O-dimethyl nobiletin crystals;
⑧ After removing the residual solvent mixture in vacuum, obtaining the final crystal, 5-O-dimethyl nobiletin; consists of.

Description

청귤류로부터 5-O-디메틸노빌레틴의 추출/분리 및 만성 알코올성 지방간 손상보호 조성물 {Method for extract of citrus preicarp and composition for preventing, improving or treating liver injury}Extraction/isolation of 5-O-dimethyl nobiletin from blue citrus fruits and a composition for protecting chronic alcoholic fatty liver damage {Method for extract of citrus preicarp and composition for preventing, improving or treating liver injury}

본 발명은 청귤류로부터 폴리메틸 플라보노이드(Poly Methyl Flavonoid : ‘PMF’ 라 약칭함)의 추출물을 short flash column chromatography을 이용하여 5-O-디메틸 노빌레틴(5-O-Demethyl nobiletin)의 추출방법 및 그를 이용한 지방간 손상보호 조성물에 관한 발명이다. The present invention is a method for extracting 5-O-dimethyl nobiletin (5-O-Demethyl nobiletin) from blue citrus fruits using an extract of polymethyl flavonoid (abbreviated as 'PMF') using short flash column chromatography and The invention relates to a fatty liver damage protection composition using the same.

합성 화학물질을 이용한 의약품은 인체에 부작용을 발생하는 등의 문제점이 꾸준히 제기되어 왔다. 따라서, 최근에는 합성 화학물질로 인한 부작용을 줄이기 위해 천연물을 이용한 의약품 조성물이 다양하게 개발되고 있다.Drugs using synthetic chemicals have been constantly presented with problems such as side effects on the human body. Therefore, in recent years, in order to reduce the side effects caused by synthetic chemicals, various pharmaceutical compositions using natural products have been developed.

천연재료는 부작용이 적을 뿐만 아니라 소비자들의 호응이 높아 의약품의 원료로써 개발가치가 증가하고 있는 추세이다. 암 억제 성분인 노블레틴은 특수한 플라보노이드인 폴리 메틸 플라보노이드(Poly Methyl Flavonoid)의 일종으로 감귤류에만 함유되어 있는 성분으로 노블레틴(Nobiletin)과 탄게레틴(Tangeretin) 및 시네세틴(Sinensetin)이 발암억제, 암세포의 침입 지연, 전이방지, 종양세포의 증식억제 등 암 예방에 효과가 있는 것으로 알려져 있다. 상기와 같은 약리작용으로 인하여 노빌레틴과 탄제레틴 및 시네세틴에 대한 수요가 증가하고 있고, 이들 노빌레틴과 탄제레틴 및 시네세틴을 고함량 함유하는 추출물을 분리 정제하는 기술들이 개발되고 있다.Natural materials have fewer side effects and are highly favored by consumers, so their development value as a raw material for pharmaceuticals is increasing. Nobletin, a cancer-suppressing component, is a type of polymethyl flavonoid, a special flavonoid, and is a component contained only in citrus fruits. It is known to be effective in preventing cancer, such as delaying invasion, preventing metastasis, and inhibiting the proliferation of tumor cells. Due to the pharmacological action as described above, the demand for nobiletin, tangeretin, and synacetin is increasing, and technologies for separating and purifying extracts containing high content of nobiletin, tangeretin and synacetin are being developed.

종래의 선행기술들을 살펴보면, 국내등록특허 제1676751에 감귤류의 과피에 알코올 농도가 50~80 중량%인 함수 저급 알코올을 첨가하여 침전물 형태의 추출물인 노빌레틴(nobiletin) 및 탄저레틴(tangeretin)을 추출하는 방법이 개시되어 있고, 또한, 국내등록특허 제1588613호에는 (1) 감귤류의 과육 또는 과피를 염기성용액으로 세척하고 회수하는 단계; (2) 상기 회수물을 알콜 수용액으로 추출하여 추출물을 획득하는 단계; (3) 상기 추출물을 여과 후 농축하여 농축물을 획득하는 단계; 및 (4) 상기 농축물을 침전시키고 건조시켜 최종 산물을 얻는 단계를 포함하는 노빌레틴(Nobiletin) 또는 탄제레틴(Tangeretin) 함유 감귤류 추출물의 제조 방법이 개시되어 있으며, 국내등록특허 제0770746호에는 감귤 과피를 동결건조하고, 80% 메탄올을 넣고 추출한 후, 여과하고 농축한 다음, 이 농축물을 헥산(Hexane)과 물로 분배 추출하고, 그 중 물층을 에틸아세테이트(EtOAc)로 분배추출하고, 에틸아세테이트 추출물을 농축한 다음, 순상 칼럼 크로마토그래피를 실시하여 분획하고, 이 분획물들을 고속액체크로마토그래피를 이용하여 노빌레틴 함량이 가장 큰 분획물을 선택하고, 선택된 분획물을 재순환 분취용 액체 크로마토그래피를 이용하여 정제하는 방법이 개시되어 있다.Looking at the prior art, nobiletin and tangeretin, which are extracts in the form of precipitates, are extracted by adding water-containing lower alcohol having an alcohol concentration of 50 to 80 wt% to the peel of citrus fruits in Korean Patent No. 1676751. In addition, Korean Patent No. 1588613 discloses (1) washing the pulp or peel of citrus fruits with a basic solution and recovering; (2) extracting the recovered product with an aqueous alcohol solution to obtain an extract; (3) concentrating the extract after filtration to obtain a concentrate; and (4) precipitating and drying the concentrate to obtain a final product. A method for producing a citrus extract containing Nobiletin or Tangeretin is disclosed, and Korean Patent No. 0770746 discloses citrus fruits. The pericarp was freeze-dried, extracted with 80% methanol, filtered and concentrated, and the concentrate was partitioned and extracted with hexane and water, and the aqueous layer was partitioned with ethyl acetate (EtOAc) and extracted with ethyl acetate. After concentrating the extract, it is fractionated by normal phase column chromatography, the fraction having the highest nobiletin content is selected using high performance liquid chromatography, and the selected fraction is purified using liquid chromatography for recycle preparative. A method is disclosed.

또한, 국내등록특허 제-1825150호 및 국내등록특허 제0770746호에는 a 내지 i 단계를 거쳐 추출한 감귤 진피 추출정제물의 제조방법 및 상기 유효성분을 함유하는 간암의 예방, 개선 또는 치료용 조성물에 관한 발명이 개시되어 있다. In addition, Korean Patent No. 1825150 and Korean Patent No. 0770746 disclose a method for producing a citrus dermis extract extracted through steps a to i, and a composition for preventing, improving or treating liver cancer containing the active ingredient. This is disclosed.

그러나, 최근의 연구 결과에 의하면, 상기의 PMF 지표성분인 노빌레틴이나 탄저레틴 및 시네세틴보다는 5-O-디메틸노빌레틴이 알코올성 지방간 손상 완화에 큰 효과가 있는 것으로 확인되었다. 이에, 본 발명자들은 종래 선행기술들을 참조하여 청귤류로부터 폴리 메틸 플라보노이드(Poly Methyl Flavonoid) 추출물을 추출한 후 이들 추출물을 short flash column chromatography를 이용하여 분리 정제하여 노빌레틴과 탄제레틴 및 시네세틴을 제거하고 5-O-디메틸노빌레틴을 추출하는 새로운 추출방법을 개발하게 되었다. However, according to a recent study result, it was confirmed that 5-O-dimethyl nobiletin had a greater effect on alleviating alcoholic fatty liver damage than nobiletin, tangeretin, and synacetin, which are the PMF indicator components. Accordingly, the present inventors extracted poly methyl flavonoid extracts from blue citrus fruits with reference to prior art, and separated and purified these extracts using short flash column chromatography to remove nobiletin, tangeretin and synacetin, A new extraction method for extracting 5-O-dimethyl nobiletin was developed.

즉, 상기의 5-O-디메틸 노블레틴은 노빌레틴과 탄제레틴 및 시네세틴이 혼합된 추출물을 추출물 무게의 40배에 해당하는 실리카젤로 충진하여 n-헥산 : 에틸 아세테이트를 2 : 1의 비율로 이동상으로 하여 충진된 실리카젤 부피의 20배에 해당하는 용매를 통과시켜 노빌레틴과 시네세틴을 제거하고, 회수된 5-O-디메틸 노블레틴과 탄제레틴 혼합물을 용매인 CH2Cl2에 녹여 -20℃에서 6시간동안 방치하여 한 후, 5-O-디메틸 노블레틴을 재결정시켜 수득한 것을 확인하고 본 발명을 완성하게 되었다.That is, the 5-O-dimethyl nobletin is filled with silica gel equivalent to 40 times the weight of the extract by filling the extract containing nobiletin, tangeretin and synacetin in a ratio of 2:1 with n-hexane:ethyl acetate. Nobiletin and synacetin were removed by passing a solvent corresponding to 20 times the volume of the filled silica gel as a mobile phase, and the recovered 5- O -dimethyl nobletin and tangeretine mixture was dissolved in CH 2 Cl 2 as a solvent. After standing at -20°C for 6 hours, it was confirmed that 5-O-dimethyl nobletin was recrystallized to complete the present invention.

국내등록특허 제1676751호Domestic Registered Patent No. 1676751 국내등록특허 제1588613호Domestic Registered Patent No. 1588613 국내등록특허 제0770746호Domestic Registered Patent No. 0770746 국내등록특허 제1825150호Domestic Registered Patent No. 1825150 국내등록특허 제0770746호Domestic Registered Patent No. 0770746 국내등록특허 제1449976호Domestic Registered Patent No. 1449976 국내공개특허 제2015-0020001호Domestic Patent Publication No. 2015-0020001

본 발명은 청귤류로부터 폴리 메틸 플라보노이드의 일종인 5-O-디메틸노빌레틴의 추출방법을 개발하는 데 그 목적이 있다.An object of the present invention is to develop a method for extracting 5-O-dimethylnoviletin, a kind of polymethyl flavonoid, from blue citrus fruits.

본 발명의 또 다른 목적은 청귤류가 갖는 각각의 성분들을 분석하고 그로부터 5-O-디메틸노빌레틴을 고순도 분리 및 정제하는 방법을 제공하는데 그 목적이 있다. 또한, 본 발명은 상기의 5-O-디메틸노빌레틴을 함유하는 지방간 손상보호 조성물을 제공하는 데 발명의 목적이 있다. Another object of the present invention is to analyze each component of blue citrus fruits and provide a method for high-purity separation and purification of 5-O-dimethylnoviletin therefrom. In addition, an object of the present invention is to provide a fatty liver damage protection composition containing the 5-O-dimethyl nobiletin.

본 발명의 해결하고자 하는 과제는 본 발명자들은 오랫동안 연구한 결과, 청귤류 열매 혹은 착즙부산물로부터 5-O-디메틸노빌레틴 결정을 추출하기 위한 것으로, 이를 위해The problem to be solved by the present invention is to extract 5-O-dimethylnoviletin crystals from blue citrus fruits or juice by-products as a result of long-term research by the present inventors, for this purpose

① 청귤류 열매 혹은 착즙부산물을 분쇄기를 통해 분쇄하는 단계;① pulverizing green citrus fruits or juice by-products through a grinder;

② 상기 분쇄물을 극성 용매인 에틸 아세이트(Ethtyl acetate) 또는 이염화메틸렌(CH2Cl2)를 이용하여 추출하는 단계; ② extracting the pulverized product using a polar solvent ethyl acetate (Ethtyl acetate) or methylene dichloride (CH 2 Cl 2 );

③ 활성 탄소(activated carbon)을 이용하여 추출물에 함유되어 있는 불순물 또는 색소물질을 제거단계;③ removing impurities or coloring matter contained in the extract using activated carbon;

④ 알칼리수인 NaOH를 이용하여 추출물에 잔류하는 농약성분 등을 제거한 후 물로 세척하여 알칼리 제거하고 진공건조시켜 분말을 수득하는 진공건조단계;④ A vacuum drying step of removing the pesticides remaining in the extract using NaOH, which is alkaline water, washing with water to remove alkali, and vacuum drying to obtain a powder;

⑤ 하는 단계;⑤ to do;

⑥ 탄제레틴과 5-O-디메틸노빌레틴의 혼합물을 농축단계;⑥ Concentrating the mixture of tangeretin and 5-O-dimethyl nobiletin;

⑦ 혼합물을 이염화메틸렌에 녹여 -20℃에서 6시간동안 방치하여 용매 및 혼합물(탄제레틴은 용매에 녹아 있는 상태임)과 5-O-디메틸노빌레틴을 결정으로 분리하는 단계;⑦ Dissolving the mixture in methylene dichloride and leaving it at -20°C for 6 hours to separate the solvent and the mixture (tangeretin is dissolved in the solvent) and 5-O-dimethyl nobiletin into crystals;

⑧ 진공에서 잔류용매 혼합물을 제거 후, 최종 결정물인 5-O-디메틸노빌레틴 을 수득하는 단계; 를 포함한다.⑧ After removing the residual solvent mixture in vacuo, obtaining a final crystal of 5-O-dimethyl nobiletin; includes

본 발명의 따른 청귤류의 추출물을 통해 고순도의 5-O-디메틸 노빌레틴을 높은 함량으로 추출하였다.High-purity 5-O-dimethyl nobiletin was extracted with a high content through the extract of blue citrus fruits according to the present invention.

상기의 5-O-디메틸 노빌레틴은 유기적인 상승 작용에 의해 5-O-디메틸 노빌레틴의 처리군에서 정상적인 세포 및 핵이 관찰됨에 따라 만성 알코올성 지방간 보호에 상당히 효과가 있는 것으로 확인되었다. The above 5-O-dimethyl nobiletin was confirmed to be quite effective in protecting chronic alcoholic fatty liver, as normal cells and nuclei were observed in the group treated with 5-O-dimethyl nobiletin by an organic synergistic action.

도 1은 청귤류의 과피로부터 5-O-디메틸노빌레틴을 추출 및 분리하기 위한 공정도이다.1 is a process diagram for extracting and separating 5-O-dimethylnoviletin from the peel of blue citrus fruits.

발명에서 사용되는 용어는 가능한 현재 널리 사용되는 일반적인 용어를 선택하였으며, 특정한 경우는 출원인이 임의로 선정한 용어가 있을 수 있으나, 이는 단순한 용어의 명칭이 아닌 발명의 상세한 설명 부분에 기재되거나 사용된 의미를 고려하여 그 의미가 파악되어야 할 것이다. 폴리메틸 플라보노이드(Poly Methyl Flavonoid : PMF)의 일종인 노빌레틴(Nobiletin), 탄제레틴(Tangeretin) 및 시네세틴(Sinensetin)이 감귤류의 과피에 존재한다고 보고되었으며, 이에 따라 감귤류 과피로부터 이들 물질을 추출하기 위한 다양한 방법들이 개발되었다. 그러나 이제까지 5-O-디메틸 노빌레틴이 감귤류 과피에 존재한다는 사실은 알려져 있지 않았다.As for terms used in the invention, general terms that are currently widely used are selected as possible, and in specific cases, there may be terms arbitrarily selected by the applicant, but this takes into account the meanings described or used in the detailed description of the invention rather than the names of simple terms So the meaning should be understood. It has been reported that Nobiletin, Tangeretin, and Sinensetin, which are polymethyl flavonoids (PMF), are present in the peel of citrus fruits. Various methods have been developed for However, until now, it was not known that 5- O -dimethyl nobiletin was present in the peel of citrus fruits.

본 발명자들은 다양한 반복실험을 통하여 일반적인 잘익은 감귤류에 비하여 청귤류에 5-O-디메틸 노빌레틴이 다량 함유되어 있다는 사실을 확인하였다.The present inventors confirmed the fact that green citrus fruits contain a large amount of 5-O-dimethyl nobiletin compared to general ripe citrus fruits through various repeated experiments.

본 발명은 청귤류로부터 아래와 같은 추출방법을 통하여 5-O-디메틸 노빌레틴의 추출하였다.In the present invention, 5-O-dimethyl nobiletin was extracted from green citrus fruits through the following extraction method.

① 청귤류 열매 혹은 착즙부산물을 분쇄기를 통해 분쇄하는 단계;① pulverizing green citrus fruits or juice by-products through a grinder;

② 상기 분쇄물을 극성 용매인 에틸아세테이트 또는 이염화메틸렌를 이용하여 추출하는 단계; ② extracting the pulverized product using ethyl acetate or methylene dichloride as a polar solvent;

③ 활성탄소(activated carbon)을 이용하여 추출물에 함유되어 있는 불순물 또는 색소물질을 제거단계;③ removing impurities or coloring matter contained in the extract using activated carbon;

④ 알칼리수인 NaOH를 이용하여 추출물에 잔류하는 농약성분 등을 제거한 후 물로 세척하여 알칼리 제거하고 진공건조시켜 분말을 수득하는 진공건조단계;④ A vacuum drying step of removing the pesticides remaining in the extract using NaOH, which is alkaline water, washing with water to remove alkali, and vacuum drying to obtain a powder;

⑤ 용매인 노말-헥산 : 에틸아세테이트를 2 : 1의 비율로 한 후 컬럼 부피의 20배를 short silicagel column으로 통과시켜 노빌레틴과 시네세틴을 제거하고, 탄제레틴과 5-O-디메틸 노빌레틴의 혼합물을 분리하는 단계;⑤ After using the solvent, normal-hexane:ethyl acetate in a ratio of 2: 1, pass 20 times the column volume through a short silicagel column to remove nobiletin and synacetin, and to remove tangerine and 5-O-dimethyl nobiletin. separating the mixture;

⑥ 탄제레틴과 5-O-디메틸 노빌레틴의 혼합물을 농축단계;⑥ Concentrating the mixture of tangeretin and 5-O-dimethyl nobiletin;

⑦ 혼합물을 이염화메틸렌에 녹여 -20℃에서 6시간동안 방치하여 용매 및 혼합물(tangeretin은 용매에 녹아 있는 상태임)과 5-O-디메틸 노빌레틴 결정을 분리하는 단계;⑦ Dissolving the mixture in methylene dichloride and leaving it at -20°C for 6 hours to separate the solvent and the mixture (tangeretin is dissolved in the solvent) and 5-O-dimethyl nobiletin crystals;

⑧ 진공에서 잔류용매 혼합물을 제거 후, 최종 결정물인 5-O-디메틸 노빌레틴을 수득하는 단계;로 구성되어 있다. ⑧ After removing the residual solvent mixture in vacuum, obtaining a final crystal, 5-O-dimethyl nobiletin; consists of.

이를 구체적으로 다시 기술하면, 본 발명의 단계 ⑤에서는 화학식(1)의 시네세틴과 화학식 (2)의 노빌레틴이 제거된다.Specifically, in step ⑤ of the present invention, synacetin of formula (1) and nobiletin of formula (2) are removed.

Figure 112019043119495-pat00001
Figure 112019043119495-pat00001

Nobiletin : 1H NMR(400MHz, CDCl3) : δ7.60(dd, J=8.4Hz, J'=2.4Hz, 1H), δ7.42(d, J=2Hz, 1H), δ7.00(d, J=8.8Hz, 1H), δ6.67(s, 1H), δ 4.11(-CH3, 3H), δ4.03(- CH3, 3H), δ3.98 CH3, 3H), δ3.97(- CH3, 3H), δ3.96(- CH3, 6H) ; 13C NMR(100MHz, CDCl3) : δ177.1, δ161.10, δ152.0, δ151.5.6, δ149.3, δ149.5, δ148.4, δ147.7, δ144.1, δ138.0, δ123.9, δ119.7, δ114.8, δ111.3, δ108.6, δ106.8, δ62.3, δ61.9, δ61.7, δ56.1, δ55.9Nobiletin : 1H NMR (400MHz, CDCl 3 ): δ7.60(dd, J=8.4Hz, J’=2.4Hz, 1H), δ7.42(d, J=2Hz, 1H), δ7.00(d, J=8.8Hz, 1H), δ6.67(s, 1H), δ 4.11(-CH 3 , 3H), δ4.03(-CH 3 , 3H), δ3.98 CH 3 , 3H), δ3.97 (-CH 3 , 3H), δ3.96(-CH 3 , 6H) ; 13C NMR (100MHz, CDCl 3 ): δ177.1, δ161.10, δ152.0, δ151.5.6, δ149.3, δ149.5, δ148.4, δ147.7, δ144.1, δ138.0, δ123 .9, δ119.7, δ114.8, δ111.3, δ108.6, δ106.8, δ62.3, δ61.9, δ61.7, δ56.1, δ55.9

Sinensetin : 1H NMR(400MHz, CDCl3) : δ7.50(dd, J=8.8Hz, J'=2.4Hz, 1H), δ7.03(d, J=9.2Hz, 2H), δ6.67(s, 1H), δ 4.11(s, -OCH3, 3H), δ4.03(s, - OCH3, 3H), δ3.95(s, -OCH3, 3H), δ3.89(s, -OCH3, 3H) ; 13C NMR(100MHz, CDCl3) : δ177.3, δ161.2, δ 157.8, δ154.8, δ154.6, δ152.7, δ151.9, δ149.4, δ140.5, δ124.2, δ119.7, δ112.9, δ111.2, δ108.7, δ107.5, δ96.4, δ62.3, δ62.7, δ61.7, δ56.4, δ56.2, δ56.2Sinensetin : 1H NMR (400MHz, CDCl 3 ): δ7.50(dd, J=8.8Hz, J'=2.4Hz, 1H), δ7.03(d, J=9.2Hz, 2H), δ6.67(s) , 1H), δ 4.11 (s , -OCH 3, 3H), δ4.03 (s, - OCH 3, 3H), δ3.95 (s, -OCH 3, 3H), δ3.89 (s, -OCH 3 , 3H) ; 13C NMR (100 MHz, CDCl 3 ): δ177.3, δ161.2, δ 157.8, δ154.8, δ154.6, δ152.7, δ151.9, δ149.4, δ140.5, δ124.2, δ119. 7, δ112.9, δ111.2, δ108.7, δ107.5, δ96.4, δ62.3, δ62.7, δ61.7, δ56.4, δ56.2, δ56.2

단계 ⑦에서는 화학식 (3)의 탄제레틴은 용매에 녹아있고 추출물인 화학식 (4)의 5-O-디메틸 노빌레틴의 결정이 석출된다.In step ⑦, tangeretin of formula (3) is dissolved in a solvent, and crystals of 5-O-dimethyl nobiletin of formula (4), which is an extract, are precipitated.

Figure 112019043119495-pat00002
Figure 112019043119495-pat00002

Tangeretin : 1H NMR(400MHz, CDCl3) : δ7.89(d, J=8.84Hz, 2H), δ7.03(d, J=9.2Hz, 2H), δ6.67(s, 1H), δ 4.11(s, -OCH3, 3H), δ4.03(s, - OCH3, 3H), δ3.95(s, -OCH3, 3H), δ3.89(s, -OCH3, 3H) ; 13C NMR(100MHz, CDCl3) : δ177.4, δ162.4, δ 161.4, δ151.5, δ148.4, δ147.8, δ144.2, δ138.1, δ 127.8, δ 123.8, δ114.8, δ114.6, δ106.6, δ62.3, δ62.1, δ61.8, δ61.7, δ55.5Tangeretin : 1H NMR (400 MHz, CDCl 3 ): δ7.89(d, J=8.84Hz, 2H), δ7.03(d, J=9.2Hz, 2H), δ6.67(s, 1H), δ 4.11 (s, -OCH 3, 3H) , δ4.03 (s, - OCH 3, 3H), δ3.95 (s, -OCH 3, 3H), δ3.89 (s, -OCH 3, 3H); 13C NMR (100 MHz, CDCl 3 ): δ177.4, δ162.4, δ 161.4, δ151.5, δ148.4, δ147.8, δ144.2, δ138.1, δ 127.8, δ 123.8, δ114.8, δ114.6, δ106.6, δ62.3, δ62.1, δ61.8, δ61.7, δ55.5

5-O-Demethylnobiletin : 1H NMR(400MHz, CDCl3) : δ12.53(s, -OH), δ7.57(dd, J=8Hz, J'=2.2Hz, 1H), δ7.40(d, J=2.4Hz, 1H), δ6.98(d, J=8.8Hz, 1H), δ6.59(s, 1H), 4.10(-CH3, 3H), δ3.97(- CH3, 3H), δ3.96 CH3, 3H), δ3.94(- CH3, 3H), δ3.93(- CH3, 3H); 13C NMR(100MHz, CDCl3) : δ183.1, δ164.0, δ153.1, δ152.6, δ149.6, δ149.5, δ145.9, δ136.7, δ133.0, δ123.8, δ120.2, δ111.4, δ108.9, δ107.1, δ104.1, δ62.2, δ61.8, δ61.2, δ56.2, δ56.15-O-Demethylnobiletin : 1H NMR (400MHz, CDCl 3 ): δ12.53(s, -OH), δ7.57(dd, J=8Hz, J'=2.2Hz, 1H), δ7.40(d, J=2.4Hz, 1H), δ6.98(d, J=8.8Hz, 1H), δ6.59(s, 1H), 4.10(-CH 3 , 3H), δ3.97(-CH 3 , 3H) , δ3.96 CH 3 , 3H), δ3.94(-CH 3 , 3H), δ3.93(-CH 3 , 3H); 13C NMR (100MHz, CDCl 3 ): δ183.1, δ164.0, δ153.1, δ152.6, δ149.6, δ149.5, δ145.9, δ136.7, δ133.0, δ123.8, δ120 .2, δ111.4, δ108.9, δ107.1, δ104.1, δ62.2, δ61.8, δ61.2, δ56.2, δ56.1

상기에서 청귤류는 시쿠와사(Citrus depressa), 타치바나(C.tachibana), 코우지(C.leiocarpa), 기리귤(C.tardiva), 지미강(C.succosa), 키시우(C.kinokuni), 코베니미캉(C.erythrosa), 치츄우카이망다링(C.deliciosa), 킹(C.nobilis), 본관(C.retuculata), 탄지에린(C.tangerina), 하나 유모(C.hanaya), 코우라이 타치바나(C.nippokoreana), 진귤(C.sunki hort. ex Tanaka) 및 한라봉 (C.hybrid Shiranuhi), 무봉, 온주귤(citrus unshiu), 광귤(Citrus aurantium) 중 어느 하나를 선택하여 사용할 수 있다.In the above, the green citrus fruits are Citrus depressa, C. tachibana, Koji (C. leiocarpa), Kiri tangerine (C. tardiva), Jimigang (C. succosa), and Kishiu (C. kinokuni). , Kobeni mikang (C.erythrosa), Chichuukaimandaring (C.deliciosa), King (C.nobilis), Main building (C.retuculata), Tangierin (C.tangerina), Hana (C.hanaya), You can choose any one of Kourai Tachibana (C.nippokoreana), Ginger Tangerine (C.sunki hort. ex Tanaka), Hallabong (C.hybrid Shiranuhi), Radish Bong, Onju Tangerine (citrus unshiu), and Citrus aurantium. have.

[5-O-디메틸 노빌레틴이 알코올성 간 손상 조직에 미치는 영향][Effect of 5-O-dimethyl nobiletin on alcoholic liver damaged tissue]

알코올 투여 및 PMF 지표성분의 투여를 통한 간의 조직병리학적 변화 및 지방간 완화 효과를 확인하기 위한 H&E염색, 면역염색을 수행한 결과는 도 2에 나타내었다. 알코올 섭취가 전혀 없이 증류수만을 섭취한 정상 대조군에서는 알코올에 의한 간 손상이 보이지 않아 정상적인 간세포만을 관찰할 수 있었는데, 이 정상 대조군의 간세포들에서는 지방간을 판단할 수 있는 가장 대표적인 지방방울 (lipid droplet)이 관찰되지 않았으며, 지방의 침착 (lipid accumulation) 또한 관찰되지 않았고, 상대적으로 핵의 모양이 뚜렷하게 관찰되었다. 정상 대조군의 간세포와 다르게, 실험기간동안 알코올을 처리한 대조군에서는 간 조직의 손상을 확연하게 관찰할 수 있었다. 간세포에서 지방 침착으로 인해 세포의 풍선형 변형과 말로리소체, 파괴된 핵이 관찰되었으며, 이러한 형태의 세포 및 파괴된 핵은 지방간을 판정하는 지표이다. MIX(D), 탄제레틴(F), 5-O-디메틸 노빌레틴(G) 처리군에서 정상적인 세포 및 핵이 관찰됨에 따라 만성 알코올성 지방간 보호에 상당히 효과가 있는 것으로 관찰되었다. 반면, 노빌레틴 처리군(E)에서는 완화 효과를 나타내지 않았다(그림 1 참조 ).The results of H&E staining and immunostaining to confirm the liver histopathological change and fatty liver relief effect through the administration of alcohol and PMF indicator components are shown in FIG. 2 . In the normal control group, which consumed only distilled water without any alcohol intake, there was no alcohol-induced liver damage and only normal hepatocytes could be observed. It was not observed, lipid accumulation was also not observed, and the shape of the nucleus was relatively clearly observed. Unlike the hepatocytes of the normal control group, damage to the liver tissue was clearly observed in the control group treated with alcohol during the experiment period. Due to fat deposition in hepatocytes, balloon-shaped deformation of cells, mallysosomes, and destroyed nuclei were observed, and these types of cells and destroyed nuclei are indicators for judging fatty liver. As normal cells and nuclei were observed in the MIX (D), tangeretin (F), and 5-O-dimethyl nobiletin (G) treated groups, it was observed that the treatment was significantly effective in the protection of chronic alcoholic fatty liver. On the other hand, nobiletin treatment group (E) showed no alleviating effect (see Figure 1).

[그림 1] 청귤류 추출물 중의 PMF에 대한 간 조직병리분석[Figure 1] Hepatic histopathological analysis of PMF in blue citrus extract

Figure 112019043119495-pat00003
Figure 112019043119495-pat00003

특히, PMF 지표성분이 알코올성 지방간에 미치는 영향을 알기 위하여, 전 염증 효소인 TNF-α를 이용하여 면역염색을 진행한 결과, 정상 대조군과 5-O-디메틸 노빌레틴(G)를 섭취 한 그룹에서는 TNF-α 양성반응이 관찰되지 않았다. 그러나 알코올을 섭취한 그룹과 노빌레틴(D)을 섭취한 그룹에서는 혈관을 중심으로 강한 양성 반응을 관찰할 수 있었고, MIX(D), 탄제레틴(F)를 섭취한 그룹에서도 비교적 약한 양성 반응을 관찰할 수 있었다(그림 2참조). In particular, in order to determine the effect of the PMF indicator component on alcoholic fatty liver, immunostaining was performed using the pro-inflammatory enzyme TNF-α. As a result, in the normal control group and the group taking 5-O-dimethyl nobiletin (G), No TNF-α positive reaction was observed. However, a strong positive reaction was observed centered on blood vessels in the group that consumed alcohol and the group that consumed nobiletin (D), and a relatively weak positive reaction was also observed in the group that consumed MIX (D) and tangeretin (F). could be observed (see Figure 2).

[그림 2] 청귤류 PMF에 대한 TNF-α 분포를 이용한 간의 면역조직병리분석 [Figure 2] Hepatic immunohistopathological analysis using TNF-α distribution for green citrus PMF

Figure 112019043119495-pat00004
Figure 112019043119495-pat00004

[5-O-디메틸 노빌레틴이 혈액의 생화학적 성분에 미치는 영향][Effect of 5-O-dimethyl nobiletin on the biochemical composition of blood]

알코올에 의해 간이 손상될수록 혈액학적으로 유의한 변화가 있기에 PMF 지표성분 섭취 및 알코올 섭취한 동물 모델에서 혈 등에 액내의 생화학적 성분의 변화를 확인한 혈액 검사 수행 결과는 다음과 같다. 알코올 및 PMF 지표성분을 함께 투여 한 마우스의 혈액 중 혈청 내의 간 손상과 관련된 단백질 중 대표적인 단백질인 ALT, AST, 중성지방(TG)의 수치 변화를 측정할 수 있었다.As the liver is damaged by alcohol, there are significant hematologic changes, so the blood test results confirming the changes in the biochemical components in the blood, etc. in the animal model ingesting the PMF indicator component and ingesting alcohol are as follows. Changes in levels of ALT, AST, and triglycerides (TG), which are representative proteins related to liver damage, were measured in the blood serum of mice administered with alcohol and PMF indicator components.

혈중 ALT와 AST는 일반적으로 간 조직이 손상을 입게 되면 혈중으로 방출되는 효소로 알려져 있어 간 손상의 지표로 널리 사용되고 있으며, 정상 대조군(이하 CON)보다 알코올(이하 NC) 처리 군에서 유의적으로 높은 혈중 ALT, AST의 활성을 보였다. 그림 3과 같이 PMF 지표성분을 투여 처리군 중 전체가 포함되어있는 mixture(이하 MIX)과 노빌레틴(NB) 처리군에서는 알코올 처리군에 비해 유의적으로 혈중 ALT, AST의 활성이 낮은 것으로 보이고, 탄제레틴, 5-O-디메틸노빌레틴 처리군에서는 정상 대조군 보다 유의적으로 비슷한 ALT, AST의 활성을 나타내었다. 결론적으로 청귤류 지표성분 전체가 ALT와 AST감소에 효과적이며, 특히, 탄제레틴 및 5-O-디메틸 노빌레틴 처리군은 정상군과 가깝게 매우 효과적인 효능을 나타내었다.Blood ALT and AST are generally known as enzymes released into the blood when liver tissue is damaged and are widely used as indicators of liver damage, and were significantly higher in the alcohol (NC) treatment group than in the normal control group (CON). Blood ALT and AST activity were shown. As shown in Figure 3, in the mixture (hereinafter referred to as MIX) and the nobiletin (NB) treatment group containing all of the PMF indicator components, the blood ALT and AST activity were significantly lower than in the alcohol treatment group, The tangeretin and 5-O-dimethyl nobiletin-treated groups showed significantly similar ALT and AST activities than the normal control group. In conclusion, all of the green citrus indicator components were effective in reducing ALT and AST, and in particular, the tangeretine and 5-O-dimethyl nobiletin-treated groups showed very effective efficacy close to that of the normal group.

[그림 3] 청귤류 PMF에 대한 혈액병리분석 [Figure 3] Hemopathological analysis of blue citrus PMF

Figure 112019043119495-pat00005
Figure 112019043119495-pat00005

[5-O-디메틸 노빌레틴이 CYP2E1 발현에 미치는 영향][Effect of 5-O-dimethyl nobiletin on CYP2E1 expression]

산화적 스트레스의 원인에는 알코올에 의한 활성 산소의 증가가 있으며, 이는 알코올성 간 손상의 핵심적인 역할을 한다. 이에 생체에서는 산화적 스트레스를 완화시키기 위해 높은 수준의 CYP2E1의 발현을 보이며, 이는 간 손상 상태의 정도를 측정할 주된 지표이다. 따라서 본 실험에서도 간 내의 CYP2E1 발현량을 정량화하기 위하여 western blot을 수행하였다. 증류수만을 투여한 정상 처리군에서는 측정하고자 하는 단백질인 CYP2E1의 단백질 수치가 거의 발현하지 않은 정도를 보였고, 알코올 처리 군은 정상 처리군에 비해 약 2배 가까운 CYP2E1의 발현량을 보이며, 통계적으로 유의하게 높게 발현된 것을 알 수 있었다. 또한 PMF 지표성분 중 탄제레틴과 5-O-디메틸 노빌레틴 투여한 그룹에서 CYP2E1의 발현량이 정상군과 유사하게 감소한 것을 그림 4에서 같이 볼 수 있었다.The cause of oxidative stress is an increase in free radicals caused by alcohol, which plays a key role in alcoholic liver damage. Accordingly, in vivo, high levels of CYP2E1 expression are shown to alleviate oxidative stress, which is a major indicator to measure the degree of liver damage. Therefore, in this experiment, western blot was performed to quantify the expression level of CYP2E1 in the liver. In the normal treatment group administered only with distilled water, the protein level of CYP2E1, the protein to be measured, was almost not expressed, and in the alcohol treatment group, the expression level of CYP2E1 was approximately twice that of the normal treatment group, which was statistically significant. was found to be highly expressed. Also, as shown in Figure 4, the expression level of CYP2E1 decreased in the group administered with tangeretin and 5-O-dimethyl nobiletin among the PMF indicator components, similar to that of the normal group.

[그림 4] 청귤류 PMF에 대한 CYP2E1 단백질 발현분석[Figure 4] Analysis of CYP2E1 protein expression in blue citrus PMF

Figure 112019043119495-pat00006
Figure 112019043119495-pat00006

[5-O-디메틸 노빌레틴이 TNF-α 발현에 미치는 영향 ][Effect of 5-O-dimethyl nobiletin on TNF-α expression]

NF-α 발현량을 정량화하기 위하여 실험을 수행하였으며, 증류수만을 투여한 정상 처리군에서는 측정하고자 하는 TNF-α의 수치가 거의 발현하지 않은 정도를 보였고, 알코올 처리 군은 정상 처리군에 비해 약 2배 가까운 TNF-α의 발현량을 보이며, 통계적으로 유의하게 높게 발현된 것을 알 수 있었다. 또한 PMF 지표성분을 투여한 그룹에서 TNF-α의 발현량이 정상군과 유사하게 감소한 것을 볼 수 있었으며, 특히 탄제레틴과 5-O-디메틸 노빌레틴 처리군에서 정상군과 유사한 발현량을 나타내었다. 결과적으로, 지표성분 전체가 TNF-α발현억제에 매우 효과적이며, 그림 5와 같이 탄제레틴과 5-O-디메틸 노빌레틴이 가장 좋은 결과를 나타내었다.An experiment was performed to quantify the NF-α expression level, and the normal treatment group administered only with distilled water showed almost no expression of the level of TNF-α to be measured, and the alcohol treatment group showed about 2% compared to the normal treatment group. It could be seen that the expression level of TNF-α was close to twice that of TNF-α, and the expression level was statistically significantly high. In addition, it could be seen that the expression level of TNF-α in the group administered with the PMF indicator component decreased similarly to the normal group, and in particular, the expression level of tangeretin and 5-O-dimethyl nobiletin treated group was similar to that of the normal group. As a result, the entire index component was very effective in inhibiting TNF-α expression, and as shown in Figure 5, tangeretin and 5-O-dimethyl nobiletin showed the best results.

[그림 5] 청귤류 PMF에 대한 TNF-α 발현분석[Figure 5] TNF-α expression analysis for green citrus PMF

Figure 112019043119495-pat00007
Figure 112019043119495-pat00007

Claims (6)

청귤류 열매 혹은 착즙부산물을 분쇄기를 통해 분쇄하는 제1단계;
상기 분쇄물을 극성 용매인 에틸아세테이트 또는 이염화메틸렌를 이용하여 추출하는 제2단계;
활성탄소(activated carbon)을 이용하여 추출물에 함유되어 있는 불순물 또는 색소물질을 제거하는 제3단계;
알칼리수인 NaOH를 이용하여 추출물에 잔류하는 농약성분 등을 제거한 후 물로 세척하여 알칼리 제거하고 진공건조시켜 분말을 수득하는 진공 건조하는 제4단계;
용매인 노말-헥산 : 에틸아세테이트를 2 : 1의 비율로 한 후 컬럼 부피의 20배를 short silicagel column으로 통과시켜 화학식 (1)의 시네세틴과 화학식 2의 노빌레틴을 제거하고, 화학식 (3) 탄제레틴과 화학식 (4) 5-O-디메틸 노빌레틴의 혼합물을 분리하는 제5단계;
탄제레틴과 5-O-디메틸 노빌레틴의 혼합물을 농축하는 제6단계;
상기 혼합물을 이염화메틸렌에 녹인 후 방치하여 5-O-디메틸 노빌레틴의 결정을 분리하는 제7단계;
로 구성되는 것을 특징으로 하는 청귤류로부터 화학식 (4)의 5-O-디메틸 노빌레틴의 추출 분리방법.
Figure 112021061051998-pat00011

Figure 112021061051998-pat00012
A first step of pulverizing green citrus fruits or juice by-products through a grinder;
a second step of extracting the pulverized product using ethyl acetate or methylene dichloride as a polar solvent;
a third step of removing impurities or coloring matter contained in the extract using activated carbon;
a fourth step of vacuum-drying to obtain a powder by removing the pesticides remaining in the extract using NaOH, which is alkaline water, washing with water to remove alkali, and vacuum drying;
After using the solvent, normal-hexane:ethyl acetate in a ratio of 2:1, 20 times the volume of the column was passed through a short silicagel column to remove synacetin of Formula (1) and nobiletin of Formula 2, and formula (3) a fifth step of separating a mixture of tangeretine and formula (4) 5-O-dimethyl nobiletin;
a sixth step of concentrating a mixture of tangeretin and 5-O-dimethyl nobiletin;
a seventh step of dissolving the mixture in methylene dichloride and leaving it to stand to separate crystals of 5-O-dimethyl nobiletin;
Extraction separation method of 5-O-dimethyl nobiletin of formula (4) from blue citrus fruits, characterized in that consisting of.
Figure 112021061051998-pat00011

Figure 112021061051998-pat00012
제1항에 있어서,
청귤류는 시쿠와사(Citrus depressa), 타치바나(C.tachibana), 코우지 (C.leiocarpa), 기리 귤(C.tardiva), 지미 강(C.succosa), 키시우(C.kinokuni), 코베니미캉(C.erythrosa), 치츄우카이망다링(C.deliciosa), 킹(C.nobilis), 본관(C.retuculata), 탄지에린(C.tangerina), 하나 유모(C.hanaya), 코우라이 타치바나(C.nippokoreana), 진귤(C.sunki hort. ex Tanaka) 및 한라봉 (C.hybrid Shiranuhi), 무봉, 온주귤(citrus unshiu), 광귤(Citrus aurantium) 중 어느 하나인 것을 특징으로 하는 5-O-디메틸 노빌레틴의 추출 분리방법.
According to claim 1,
Green citrus fruits include Citrus depressa, C.tachibana, Koji (C.leiocarpa), Giri mandarin (C.tardiva), Jimigang (C.succosa), Kishiu (C.kinokuni), and koji. C.erythrosa, C.deliciosa, King (C.nobilis), Main Building (C.retuculata), Tangerina (C.tangerina), Yumo Hana (C.hanaya), Kourai Tachibana (C.nippokoreana), ginseng (C.sunki hort. ex Tanaka) and hallabong (C.hybrid Shiranuhi), radish, onju tangerine (citrus unshiu), light tangerine (Citrus aurantium) 5- Extraction separation method of O-dimethyl nobiletin.
제1항에 있어서,
7단계에서 잔류용매를 진공상태에서 제거하고 5-O-디메틸 노빌레틴 결정을 석출하는 것을 특징으로 하는 청귤류로부터 5-O-디메틸 노빌레틴의 추출 분리 방법.
According to claim 1,
A method for extracting and separating 5-O-dimethyl nobiletin from blue citrus fruits, characterized in that the residual solvent is removed in vacuum in step 7 and 5-O-dimethyl nobiletin crystals are precipitated.
삭제delete 삭제delete 삭제delete
KR1020190048840A 2019-04-26 2019-04-26 Method for extract of citrus preicarp and composition for preventing, improving or treating liver injury KR102279861B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190048840A KR102279861B1 (en) 2019-04-26 2019-04-26 Method for extract of citrus preicarp and composition for preventing, improving or treating liver injury

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190048840A KR102279861B1 (en) 2019-04-26 2019-04-26 Method for extract of citrus preicarp and composition for preventing, improving or treating liver injury

Publications (2)

Publication Number Publication Date
KR20200125086A KR20200125086A (en) 2020-11-04
KR102279861B1 true KR102279861B1 (en) 2021-07-20

Family

ID=73571608

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190048840A KR102279861B1 (en) 2019-04-26 2019-04-26 Method for extract of citrus preicarp and composition for preventing, improving or treating liver injury

Country Status (1)

Country Link
KR (1) KR102279861B1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100770746B1 (en) 2006-06-15 2007-10-30 제주대학교 산학협력단 .nobiletin from citrus having anti-inflammation activity and the method of separation and purify
KR100883356B1 (en) * 2006-08-16 2009-02-11 제주대학교 산학협력단 Compositions for Improving Obesity
US20100273727A1 (en) 2007-12-28 2010-10-28 Unitika Ltd. Oral administration composition
KR20110134742A (en) * 2010-06-09 2011-12-15 제주대학교 산학협력단 Composition for preventing or treating inflammation comprising extract of citrus sunki hort. or compounds isolated therefrom
KR101301971B1 (en) * 2011-09-30 2013-08-30 한국식품연구원 Composition of citrus peel extract or narirutin for suppressing alcoholic liver disease and method of producing narirutin extract from citrus peel
TWI559919B (en) 2013-08-16 2016-12-01 Greenyn Biotechnology Co Ltd The uses of hydroxyl polymethoxylflavones and/or derivative thereof
KR101588613B1 (en) 2013-12-16 2016-01-27 명지대학교 산학협력단 Method for producing citrus fruits extract with high nobiletin or tangeretin content and use thereof
KR101676751B1 (en) 2015-03-20 2016-11-17 주식회사 뉴트라팜텍 Method for manufacturing extract of citrus preicarp and composition for preventing, improving or treating liver injury
KR101825150B1 (en) 2015-07-30 2018-03-14 경상대학교산학협력단 Method for preparing purified extract of Citrus spp. fruit peels having an effect of inducing apoptosis of hepatocellular carcinoma cell

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Journal of Agricultural and Food Chemistry. 2016, Vol. 64, No. 10, pp. 2053-2061
Journal of Functional Foods. 2018, Vol. 47, pp. 28-39
육태원 충북대학교 석사 학위논문. 2015. AMP-activated Protein Kinase 활성화를 통한 Nobiletin의 간세포 지질축적 감소효과

Also Published As

Publication number Publication date
KR20200125086A (en) 2020-11-04

Similar Documents

Publication Publication Date Title
Truong et al. Evaluation of the use of different solvents for phytochemical constituents, antioxidants, and in vitro anti-inflammatory activities of Severinia buxifolia
Li et al. HPLC fingerprint analysis of Phyllanthus emblica ethanol extract and their antioxidant and anti-inflammatory properties
Yang et al. Hepatoprotective effects of polyprenols from Ginkgo biloba L. leaves on CCl4-induced hepatotoxicity in rats
JP5122060B2 (en) Anti-aging agent
Chen et al. Caffeoylquinic acid derivatives isolated from the aerial parts of Gynura divaricata and their yeast α-glucosidase and PTP1B inhibitory activity
Park et al. Narirutin fraction from citrus peels attenuates alcoholic liver disease in mice
Liuzzi et al. Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients
CN103211732A (en) Preparation method and application of mixture with tyrosinase inhibitory activity
Lian et al. Effects of grape seed proanthocyanidin on Alzheimer's disease in vitro and in vivo
CN104557823B (en) Rosin type diterpene derivative as well as preparation method and application thereof
Kazi et al. A natural musaceas plant extract inhibits proteasome activity and induces apoptosis selectively in human tumor and transformed, but not normal and non-transformed, cells
Kim et al. Protective effect of ginsenoside Rb1 on hydrogen peroxide-induced oxidative stress in rat articular chondrocytes
Castro et al. Potent schistosomicidal constituents from Garcinia brasiliensis
CN104292278A (en) Myrobalan tannin compounds, and preparation method and applications thereof
KR102279861B1 (en) Method for extract of citrus preicarp and composition for preventing, improving or treating liver injury
CN101157733B (en) Method for abstracting dihydroquercetin and arabinogalactan from larch and processing residual thereof
Chen et al. Active constituent in the ethyl acetate extract fraction of Terminalia bellirica fruit exhibits antioxidation, antifibrosis, and proapoptosis capabilities in vitro
CN111135221A (en) Extract of young citrus fruit and application thereof
Shim et al. The effects of panduratin A isolated from Kaempferia pandurata on the expression of matrix metalloproteinase-1 and type-1 procollagen in human skin fibroblasts
CN101445456B (en) Method for extracting and separating chlorogenic acid from chrysanthemum
KR20130024539A (en) N-butanol substracts of ecklonia cava for preventing obesity
CN105348333A (en) Allyl phenol bioside compound and preparation method and application thereof
CN103655628A (en) Propolis extract and application thereof
CN103497091A (en) Compound with tyrosinase inhibitory activity and preparation method thereof
CN102188465A (en) Preparation method of hedera plant extractives and purposes thereof

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant